How a virus contributes to cancer development in low-oxygen environments
Official title: Project 2: KSHV induces tumorigenesis by harnessing differentiation in hypoxia
Funded at University of Pennsylvania · NIH-10914918 · Data updated 2026-11-12
This study is looking at how a virus linked to Kaposi's sarcoma might help cancer grow in areas of the body where there's not enough oxygen, with the hope of finding new ways to treat this type of cancer.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $455,512 |
| NIH project number | 5P01CA281867-02 |
| Project ID | NIH-10914918 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Kaposi's sarcoma or those at high risk due to HIV/AIDS.
✕Less likely to help
Patients with cancers unrelated to HIV/AIDS or those without any form of Kaposi's sarcoma may not benefit from this research.
What this research studies
This research investigates how the Kaposi's sarcoma-associated herpesvirus (KSHV) influences the development of Kaposi's sarcoma (KS) in areas of the body with low oxygen levels. It focuses on the role of hypoxia, a condition common in solid tumors, and how KSHV may exploit this environment to promote the transformation of mesenchymal stem cells into cancerous cells. By studying the interactions between KSHV and the body's cells, the research aims to uncover the mechanisms that lead to tumor formation and progression in KS. This could provide insights into potential therapeutic targets for treating this type of cancer.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing or treating Kaposi's sarcoma in patients with HIV/AIDS.
How similar studies have gone: Previous research has shown that understanding the role of hypoxia in cancer can lead to significant advancements in treatment, suggesting that this approach may yield valuable insights.
Where this research is happening
-
University of Pennsylvania
Philadelphia, United States Active
Researchers
- Principal investigator: Yuan, Yan — University of Pennsylvania
- Study coordinator: Yuan, Yan
Related research
Other NIH-funded projects on the same topics.
-
Using MRI to measure brain oxygen levels as an early sign of small vessel disease in the brain
This study is looking at how measuring oxygen levels in the brain with MRI can help spot early signs of small vessel disease, which is linked to memory problems and dementia, especially Alzheimer's, so if you're at risk due to age or high blood pressure, you might be able to participate in MRI scans to learn more about
-
HIF-driven ways to repair damaged lungs in IPF
A doctor-researcher is testing how low-oxygen signals (HIF) could help restore healthy lung tissue in people with IPF.
-
Neonatal Brain Injury Protection with New Purine Compounds
A new medication approach using purine derivatives is being studied to protect newborn brains from injury caused by limited blood flow and oxygen during birth.
-
Aldo-keto reductase (AKR) helps brain BH4 levels after injury
This grant tests whether brain AKR enzymes can boost BH4 levels and support better brain function after hypoxia-ischemia-related injury.
-
Dual-hypoxia and proliferation PET biomarker for recurrent glioblastoma
A study using a special PET imaging approach to map oxygen-poor areas and cell growth in recurrent brain tumors to guide treatment decisions.
-
How low oxygen and genetic tweaks may repair mitochondrial problems linked to Alzheimer’s and other disorders
A Johns Hopkins-style? (Note: institution specified later) patient-facing overview: researchers will study tiny cell power stations in mitochondria to see if low-oxygen conditions and specific genetic changes can fix problems associated with Alzheimer's disease and related dementias.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.